Vispārējā ķirurģija
Hemostāzes kontrole un optimizācija
Antifibrinolītiskie līdzekļi
Tranexamic acid demonstrates efficacy without increased risk for venous thromboembolic events in cranial neurosurgery: systematic review of the evidence and current applications in nontraumatic pathologies. (opens new window)
Avots: World Neurosurg 2024;183:29-40.
Raksts indeksēts: PubMed 38052364
DOI: 10.1016/j.wneu.2023.11.148
https://pubmed.ncbi.nlm.nih.gov/38052364/ (opens new window)
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (opens new window)
Avots: Cochrane Database Syst Rev 2011;(3):CD001886.
Raksts indeksēts: PubMed 21412876
DOI: 10.1002/14651858.CD001886.pub4
https://www.ncbi.nlm.nih.gov/pubmed/21412876 (opens new window)
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. (opens new window)
Avots: BMJ 2012;344:e3054.
Raksts indeksēts: PubMed 22611164
https://www.ncbi.nlm.nih.gov/pubmed/22611164 (opens new window)
Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. (opens new window)
Avots: Br J Surg 2013;100(10):1271-9.
Raksts indeksēts: PubMed 23839785
DOI: 10.1002/bjs.9193
https://www.ncbi.nlm.nih.gov/pubmed/23839785 (opens new window)
Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. (opens new window)
Avots: JAMA Surg 2021;156(6):e210884.
Raksts indeksēts: PubMed 33851983
DOI: 10.1001/jamasurg.2021.0884
https://www.ncbi.nlm.nih.gov/pubmed/33851983 (opens new window)
Aktivēts rekombinants VII faktors (rFVIIa)
Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (opens new window)
Avots: Acta Anaesthesiol Scand 2012;56(5):636-44.
Raksts indeksēts: PubMed 22489992
DOI: 10.1111/j.1399-6576.2012.02688.x
https://www.ncbi.nlm.nih.gov/pubmed/22489992 (opens new window)
Koagulācijas faktoru koncentrāti
Fibrinogen replacement therapy: a critical review of the literature. (opens new window)
Avots: Blood Transfus 2012;10(1):23-7.
Raksts indeksēts: PubMed 22153684
DOI: 10.2450/2011.0015-11
https://www.ncbi.nlm.nih.gov/pubmed/22153684 (opens new window)
Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (opens new window)
Avots: Transfusion 2014;54(5):1389-405.
Raksts indeksēts: PubMed 24117955
DOI: 10.1111/trf.12431
https://www.ncbi.nlm.nih.gov/pubmed/24117955 (opens new window)
Viskoelasticitātes testi, lai noteiktu ķirurģisko vai koagulopātijas asiņošanu
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. (opens new window)
Avots: Eur J Anaesthesiol 2013;30(6):270-382.
Raksts indeksēts: PubMed 23656742
DOI: 10.1097/EJA.0b013e32835f4d5b
https://www.ncbi.nlm.nih.gov/pubmed/23656742 (opens new window)